市场调查报告书
商品编码
1465144
基因表现分析市场:按产品、应用和最终用户划分 - 2024-2030 年全球预测Gene Expression Analysis Market by Offering (Instruments, Reagents & Consumables, Services), Application (Clinical Diagnostics, Drug Discovery & Development), End-user - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年基因表现分析市场规模为40亿美元,2024年达43亿美元,2030年预计将达67.7亿美元,复合年增长率为7.80%。
基因表现分析是指研究基因转录和翻译为蛋白质的模式和水平的过程,突显基因在各种生物背景下的功能成分。该分析涉及量化不同条件、组织或时间点下基因的表达水平,以阐明它们在生理或病理条件下的调节机制、相互作用和作用。从基因表现分析中获得的见解对于了解疾病的分子基础、确定潜在的治疗标靶和开发个人化医疗方法至关重要。在高通量和次世代定序等技术进步的推动下,基因表现分析市场正在快速发展,从而降低了成本并提高了效率。随着遗传疾病和癌症发生率的增加,在基因组学研究方面的大量公共和私人投资的推动下,诊断和研究领域对精确基因表现研究的需求不断增加。然而,市场面临重大障碍,包括严格的法律规范延长了产品开发时间并增加了成本,以及管理和解释所产生的大量资料的复杂性。儘管存在这些挑战,未来的市场机会在于人们对个人化医疗以及人工智慧和机器学习的整合以简化资料分析的兴趣日益浓厚。
主要市场统计 | |
---|---|
基准年[2023] | 40亿美元 |
预测年份 [2024] | 43亿美元 |
预测年份 [2030] | 67.7亿美元 |
复合年增长率(%) | 7.80% |
更多采用具有特异性和扩充性的先进设备
用于基因表现分析的设备包括即时PCR(qPCR) 系统、次世代定序仪(NGS) 平台、微阵列和其他用于测量基因表现量的专用设备。微阵列扫描仪透过萤光扫描 DNA 微阵列玻片进行操作,在基因表现分析中发挥重要作用。这些仪器可实现高通量分析,使研究人员能够同时分析多个样本中大量基因的表现。 NGS 平台对于现代基因组研究至关重要,并提供更深入的资料。聚合酵素链锁反应(PCR) 是一种广泛使用的扩增特定 DNA 序列的技术,已成为基因表现分析的重要工具,尤其是定量 mRNA 水平的工具。即时PCR因其准确性、灵敏度和速度而成为检测和定量核酸的新标准。
试剂和耗材包括执行基因表现分析所需的所有输入,例如 PCR 试剂、缓衝液、引子、探针和专为特定平台和应用设计的套件。检测方法和套件对于各种基因研究和临床诊断应用的基因表现分析至关重要。这些产品旨在简化、加速和改进基因表现研究。 DNA 微阵列技术为同时分析数千个基因的表现模式提供了强大的平台。这项技术使研究人员能够全面了解疾病的机制、遗传变异和细胞路径。酵素是基因表现分析工作流程中的关键试剂,可实现逆转录、DNA 扩增和 cDNA 合成等各种重要过程。各种类型的酶,例如逆转录酶、DNA聚合酵素和连接酶,都可以找到特定于基因表现分析技术的应用。
基因表现分析服务包括咨询、客自订分析设计、样品製备、定序、资料分析和解释。这些通常由专业公司或卓越学术中心向没有必要设备或专业知识的研究人员提供。
基因表现分析在提高药物发现标靶识别应用效率的重要性日益增强
基因表现分析对于临床诊断至关重要,能够识别疾病特异性生物标记并促进个人化治疗计划。透过分析患者样本中的基因表现水平,医疗保健相关人员可以在分子层面诊断疾病、预测疾病进展并监测患者对治疗的反应。在药物发现和药物开发中,基因表现分析用于识别潜在的药物标靶,了解新药的作用机制,并预测药物的功效和毒性。这将使开发更有效、更安全的药物成为可能,显着改善药物开发平臺。
区域洞察
美洲尤其是北美的基因表现分析市场正呈现显着成长。这是由于多种因素造成的,包括先进的医疗基础设施、对生物技术和药物研究的大量投资以及大型市场参与者的存在。美国国立卫生美国(NIH) 等政府机构的倡议以及学术机构和生物製药公司之间的合作也为该地区的强劲增长做出了贡献。慢性病和遗传患者病率的上升以及与医疗保健研究相关的政府支持政策解释了欧洲基因表现分析技术的高采用率。对研究基础设施的投资和对改善医疗保健日益增长的兴趣,特别是在波湾合作理事会(GCC) 国家,是推动 EMEA 市场的关键因素。亚太地区是一个快速成长的基因表现分析市场,药物发现和市场开拓的研究活动不断增加,医疗保健支出不断增加,人们对遗传疾病的认识也不断提高。此外,旨在加强生物技术和製药行业的政府倡议以及学术机构和行业之间的合作,极大地支持了该地区的市场成长。
FPNV定位矩阵
FPNV定位矩阵对于评估基因表现分析市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对基因表现分析市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.基因表现分析市场的市场规模与预测是多少?
2.在基因表现分析市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.基因表现分析市场的技术趋势与法规结构是什么?
4.基因表现分析市场主要厂商的市场占有率为何?
5.进入基因表现分析市场合适的型态和策略手段是什么?
[188 Pages Report] The Gene Expression Analysis Market size was estimated at USD 4.00 billion in 2023 and expected to reach USD 4.30 billion in 2024, at a CAGR 7.80% to reach USD 6.77 billion by 2030.
Gene expression analysis refers to the process of studying the patterns and levels at which genes are transcribed and translated into proteins, underscoring the functional elements of genes in various biological contexts. This analysis encompasses quantifying the expression levels of genes across different conditions, tissues, or time points to elucidate their regulatory mechanisms, interactions, and roles in physiological or pathological states. The insights gained from gene expression analysis are pivotal for understanding the molecular foundations of diseases, identifying potential therapeutic targets, and developing personalized medicine approaches. The gene expression analysis market is undergoing rapid evolution propelled by technological advancements, such as high-throughput and next-generation sequencing, which have improved efficiency while reducing costs. This, alongside the increasing incidence of genetic disorders and cancer, raises the need for precise gene expression studies in both diagnostic and research realms, further buoyed by substantial investments from public and private entities in genomics research. However, the market faces substantial hurdles, including stringent regulatory frameworks that lengthen product development timelines and elevate costs, as well as the complexities associated with managing and interpreting vast amounts of data generated. Despite these challenges, future market opportunities lie in the rising interest in personalized medicine and the integration of artificial intelligence and machine learning to streamline data analysis.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.00 billion |
Estimated Year [2024] | USD 4.30 billion |
Forecast Year [2030] | USD 6.77 billion |
CAGR (%) | 7.80% |
Offering: Growing adoption of advanced instruments with specificity and scalability
Instruments for gene expression analysis include real-time PCR (qPCR) systems, next-generation sequencing (NGS) platforms, microarrays, and other specialized equipment used in measuring the expression levels of genes. Microarray scanners are instrumental in gene expression analysis, operating by fluorescently scanning DNA microarray slides. These devices enable high-throughput analysis, allowing researchers to simultaneously analyze the expression of a number of genes within multiple samples. NGS platforms are crucial to modern genomics research, providing an enhanced depth of data. Polymerase chain reaction (PCR) is a widely used technique that amplifies specific DNA sequences, making it a crucial tool for gene expression analysis, particularly in quantifying mRNA levels. Real-time PCR has become the new standard for detecting and quantifying nucleic acids owing to its precision, sensitivity, and speed.
Reagents and consumables encompass all the necessary inputs required to perform gene expression analysis, such as PCR reagents, buffers, primers, probes, and kits designed for specific platforms or applications. Assays and kits are pivotal in gene expression analysis for various genetic research and clinical diagnostic applications. These products are designed to simplify, expedite, and enhance the accuracy of gene expression studies. DNA microarray technology offers a powerful platform for the simultaneous analysis of the expression patterns of thousands of genes. This technology enables researchers to gain comprehensive insights into the underlying mechanisms of diseases, genetic variations, and cellular pathways. Enzymes are pivotal reagents in the gene expression analysis workflow, enabling various critical processes such as reverse transcription, DNA amplification, and cDNA synthesis. Different types of enzymes, such as reverse transcriptase, DNA polymerase, and ligases, find applications specific to the technique employed for gene expression analysis.
Services in gene expression analysis include consultancy, custom assay design, sample preparation, sequencing, data analysis, and interpretation. These are typically offered by specialized companies or academic core facilities to researchers lacking the necessary equipment or expertise.
Application: Rising significance of gene expression analysis in streamlining the identification of drug targets
Gene expression analysis has become integral to clinical diagnostics, enabling the identification of disease-specific biomarkers and facilitating personalized treatment plans. By analyzing the expression levels of genes in patient samples, medical professionals can diagnose diseases at a molecular level, predict disease progression, and monitor patient response to treatment. In drug discovery and development, gene expression analysis is employed to identify potential drug targets, understand the mechanisms of action of new drugs, and predict drug efficacy and toxicity. This leads to the development of more effective and safer drugs, significantly improving the drug development pipeline.
Regional Insights
The gene expression analysis market in the Americas, particularly in North America, has exhibited significant growth. This can be attributed to several factors, including advanced healthcare infrastructure, substantial investments in biotechnology and pharmaceutical research, and the presence of major market players. Initiatives by government bodies, such as the National Institutes of Health (NIH), alongside collaborations between academic institutions and biopharmaceutical companies, also contribute to the robust growth in this region. The rising prevalence of chronic and genetic diseases, combined with supportive government policies related to healthcare research, describes the high adoption of gene expression analysis technology in Europe. Investments in research infrastructure and a rising focus on healthcare improvement, particularly in the Gulf Cooperation Council (GCC) countries, are pivotal factors driving the market in the EMEA. Asia-Pacific is a rapidly growing market for gene expression analysis, with an increasing number of research activities in drug discovery and development, rising healthcare expenditures, and growing awareness about genetic diseases. Moreover, government initiatives aimed at bolstering biotechnology and pharmaceutical sectors and collaborations between academic institutions and industry are notably supporting the market growth in this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Gene Expression Analysis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Expression Analysis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Gene Expression Analysis Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSpyder, Inc., CD Genomics, Charles River Laboratories International, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina Inc., Inotiv, Inc., LGC Limited, Merck KGaA, Meridian Bioscience, Inc., NanoString Technologies Inc., New England Biolab, Oxford Gene Technology IP Limited, Oxford Nanopore Technologies plc, Promega Corporation, QIAGEN N.V., Revvity, Inc., Standard BioTools, Takara Bio, Inc., Thermo Fisher Scientific Inc, and Zymo Research Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Gene Expression Analysis Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Expression Analysis Market?
3. What are the technology trends and regulatory frameworks in the Gene Expression Analysis Market?
4. What is the market share of the leading vendors in the Gene Expression Analysis Market?
5. Which modes and strategic moves are suitable for entering the Gene Expression Analysis Market?